Alpha Tau Medical DRTS
NASDAQ DRTS
$15.03 +0.41 (+2.80%)
As of: Sep 4, 2026 · 3:59 PM EDT

Alpha Tau Medical (DRTS) Other Non-Current Assets (2020 - 2026)

Alpha Tau Medical (DRTS) posted Other Non-Current Assets of $462000.0 for Q1 2026, down 3.55% sequentially from $479000.0 in Q4 2025, and up 5.24% YoY from $439000.0 in Q1 2025.

Analysis

Alpha Tau Medical (DRTS) Other Non-Current Assets (2020 - 2026) Analysis & Trends

Alpha Tau Medical has reported Other Non-Current Assets for 7 years, with the latest figure at $462000.0 in Q1 2026.

  • Quarterly Other Non-Current Assets rose 5.24% year-over-year to $462000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $462000.0 (up 5.24% YoY) and the FY2025 annual result came in at $479000.0, up 10.88% from the prior year.
  • Other Non-Current Assets eased to $462000.0 in Q1 2026 per DRTS's latest filing, from $479000.0 in the prior quarter.
  • Over five years, Other Non-Current Assets peaked at $223.0 million in Q1 2022 and troughed at $391000.0 in Q4 2022.
  • A 5-year average of $13.6 million and a median of $441000.0 in 2023 frame the typical range for Other Non-Current Assets.
  • The widest YoY moves for Other Non-Current Assets: up 20.46% in 2023, down 99.8% in 2023.
  • Over 5 years, Other Non-Current Assets stood at $391000.0 in 2022, then gained by 20.46% to $471000.0 in 2023, then decreased by 8.28% to $432000.0 in 2024, then increased by 10.88% to $479000.0 in 2025, then slipped by 3.55% to $462000.0 in 2026.
  • According to Business Quant data, Other Non-Current Assets over the past three periods registered $462000.0, $479000.0, and $472000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.25 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 2.31 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 124.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 618.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 42.45 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 109.58 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 65.13 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 62.96 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 104.44 Mn
10 Alpha Tau Medical 1.21 Bn 1.11 Bn - 525,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 525,000.00
Mar 31, 2026 462,000.00
Dec 31, 2025 479,000.00
Sep 30, 2025 472,000.00
Jun 30, 2025 463,000.00
Mar 31, 2025 439,000.00
Dec 31, 2024 432,000.00
Sep 30, 2024 438,000.00
Jun 30, 2024 437,000.00
Mar 31, 2024 465,000.00
Dec 31, 2023 471,000.00
Sep 30, 2023 441,000.00
Jun 30, 2023 441,000.00
Mar 31, 2023 441,000.00
Dec 31, 2022 391,000.00
Sep 30, 2022 393,000.00
Jun 30, 2022 792,000.00
Mar 31, 2022 223,000.00
Dec 31, 2021 2.03 Mn
Dec 31, 2020 139,000.00